227 related articles for article (PubMed ID: 33622304)
1. Skin AGEs and diabetic neuropathy.
Papachristou S; Pafili K; Papanas N
BMC Endocr Disord; 2021 Feb; 21(1):28. PubMed ID: 33622304
[TBL] [Abstract][Full Text] [Related]
2. Skin autofluorescence is associated with severity of vascular complications in Japanese patients with Type 2 diabetes.
Tanaka K; Tani Y; Asai J; Nemoto F; Kusano Y; Suzuki H; Hayashi Y; Asahi K; Nakayama M; Miyata T; Watanabe T
Diabet Med; 2012 Apr; 29(4):492-500. PubMed ID: 21916970
[TBL] [Abstract][Full Text] [Related]
3. Skin autofluorescence and peripheral neuropathy four years later in type 1 diabetes.
Rajaobelina K; Farges B; Nov S; Maury E; Cephise-Velayoudom FL; Gin H; Helmer C; Rigalleau V
Diabetes Metab Res Rev; 2017 Feb; 33(2):. PubMed ID: 27235334
[TBL] [Abstract][Full Text] [Related]
4. Skin autofluorescence: Correlation with measures of diabetic sensorimotor neuropathy.
Stirban AO; Bondor CI; Florea B; Veresiu IA; Gavan NA
J Diabetes Complications; 2018 Sep; 32(9):851-856. PubMed ID: 30025785
[TBL] [Abstract][Full Text] [Related]
5. Skin Autofluorescence Is Associated with Diabetic Peripheral Neuropathy in Chinese Patients with Type 2 Diabetes: A Cross-Sectional Study.
Wan L; Qin G; Yan W; Sun T
Genet Test Mol Biomarkers; 2019 Jun; 23(6):387-392. PubMed ID: 31161820
[No Abstract] [Full Text] [Related]
6. Skin advanced glycation end products glucosepane and methylglyoxal hydroimidazolone are independently associated with long-term microvascular complication progression of type 1 diabetes.
Genuth S; Sun W; Cleary P; Gao X; Sell DR; Lachin J; ; Monnier VM
Diabetes; 2015 Jan; 64(1):266-78. PubMed ID: 25187362
[TBL] [Abstract][Full Text] [Related]
7. Skin autofluorescence is associated with vascular complications in patients with type 2 diabetes.
Osawa S; Katakami N; Sato I; Ninomiya H; Omori K; Yamamoto Y; Takahara M; Miyashita K; Sakamoto F; Kawamori D; Matsuoka T; Shimomura I
J Diabetes Complications; 2018 Sep; 32(9):839-844. PubMed ID: 30099985
[TBL] [Abstract][Full Text] [Related]
8. Skin autofluorescence and the complexity of complications in patients with type 2 diabetes mellitus: a cross-sectional study.
Wang X; Zhao X; Lian T; Wei J; Yue W; Zhang S; Chen Q
BMC Endocr Disord; 2021 Apr; 21(1):58. PubMed ID: 33794864
[TBL] [Abstract][Full Text] [Related]
9. Advanced glycation end products (AGEs) estimated by skin autofluorescence are related with cardiovascular risk in renal transplant.
Calviño J; Cigarran S; Gonzalez-Tabares L; Menendez N; Latorre J; Cillero S; Millan B; Cobelo C; Sanjurjo-Amado A; Quispe J; Garcia-Enriquez A; Carrero JJ
PLoS One; 2018; 13(8):e0201118. PubMed ID: 30067789
[TBL] [Abstract][Full Text] [Related]
10. Role of advanced glycation end products in diabetic neuropathy.
Sugimoto K; Yasujima M; Yagihashi S
Curr Pharm Des; 2008; 14(10):953-61. PubMed ID: 18473845
[TBL] [Abstract][Full Text] [Related]
11. Relationship between cardiac tissue glycation and skin autofluorescence in patients with coronary artery disease.
Hofmann B; Jacobs K; Navarrete Santos A; Wienke A; Silber RE; Simm A
Diabetes Metab; 2015 Nov; 41(5):410-5. PubMed ID: 25553578
[TBL] [Abstract][Full Text] [Related]
12. [The role of advanced glycation end-products (AGEs) in the development of vascular diabetic complications].
Barbosa JH; Oliveira SL; Seara LT
Arq Bras Endocrinol Metabol; 2008 Aug; 52(6):940-50. PubMed ID: 18820805
[TBL] [Abstract][Full Text] [Related]
13. Advanced glycation end-products (AGEs) accumulation in skin: relations with chronic kidney disease-mineral and bone disorder.
França RA; Esteves ABA; Borges CM; Quadros KRDS; Falcão LCN; Caramori JCT; Oliveira RB
J Bras Nefrol; 2017; 39(3):253-260. PubMed ID: 28902232
[TBL] [Abstract][Full Text] [Related]
14. The relationship between sudomotor function and skin microvascular reactivity in individuals with type 1 diabetes of long duration.
Gandecka A; Araszkiewicz A; Piłaciński S; Wierusz-Wysocka B; Zozulińska-Ziółkiewicz D
Microvasc Res; 2018 Nov; 120():84-89. PubMed ID: 30044961
[TBL] [Abstract][Full Text] [Related]
15. The pecking order of skin Advanced Glycation Endproducts (AGEs) as long-term markers of glycemic damage and risk factors for micro- and subclinical macrovascular disease progression in Type 1 diabetes.
Monnier VM; Genuth S; Sell DR
Glycoconj J; 2016 Aug; 33(4):569-79. PubMed ID: 27342131
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of tissue accumulation levels of advanced glycation end products by skin autofluorescence: A novel marker of vascular complications in high-risk patients for cardiovascular disease.
Yamagishi S; Fukami K; Matsui T
Int J Cardiol; 2015 Apr; 185():263-8. PubMed ID: 25814214
[TBL] [Abstract][Full Text] [Related]
17. Clinical Significance of Non-invasive Skin Autofluorescence Measurement in Patients with Diabetes: A Systematic Review and Meta-analysis.
Hosseini MS; Razavi Z; Ehsani AH; Firooz A; Afazeli S
EClinicalMedicine; 2021 Dec; 42():101194. PubMed ID: 34841236
[TBL] [Abstract][Full Text] [Related]
18. The association between skin autofluorescence and vascular complications in Chinese patients with diabetic foot ulcer: an observational study done in Shanghai.
Liu C; Xu L; Gao H; Ye J; Huang Y; Wu M; Xie T; Ni P; Yu X; Cao Y; Lu S
Int J Low Extrem Wounds; 2015 Mar; 14(1):28-36. PubMed ID: 25694437
[TBL] [Abstract][Full Text] [Related]
19. Skin autofluorescence, renal insufficiency and retinopathy in patients with type 2 diabetes.
Bentata R; Cougnard-Grégoire A; Delyfer MN; Delcourt C; Blanco L; Pupier E; Rougier MB; Rajaobelina K; Hugo M; Korobelnik JF; Rigalleau V
J Diabetes Complications; 2017 Mar; 31(3):619-623. PubMed ID: 28063765
[TBL] [Abstract][Full Text] [Related]
20. Association of advanced glycation end products, evaluated by skin autofluorescence, with lifestyle habits in a general Japanese population.
Isami F; West BJ; Nakajima S; Yamagishi SI
J Int Med Res; 2018 Mar; 46(3):1043-1051. PubMed ID: 29322837
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
